NThe points I have noted previously in a hypothetical case for cf33 lacking efficacy are:
1. producing no further objective responses beyond first three depsite 47 patients dosed at last update.
2. recruitment seemingly slowing down massively.
Evidence for one side, so far not much for the other.
All hypothetical of course.
- Forums
- ASX - By Stock
- Ann: Imugene onCARlytics Doses First Patient in IV Combination
NThe points I have noted previously in a hypothetical case for...
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 4542680 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 1675759 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 2598776 | 0.041 |
76 | 6281075 | 0.040 |
31 | 5664241 | 0.039 |
15 | 2789416 | 0.038 |
10 | 1400513 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 1652096 | 8 |
0.044 | 1145733 | 8 |
0.045 | 1715026 | 12 |
0.046 | 1642231 | 7 |
0.047 | 1652765 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online